Group One Trading’s Stemline Therapeutics, Inc. STML Stock Holding History

Group One Trading’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,500	Closed	-$27K	–	6479
2020 Q1	$27K	Sell	5,500 -7,300	-57%	-$47.3K	﹤0.01%	4081
2019 Q4	$136K	Buy	12,800 +12,500	+4,167%	+$124K	﹤0.01%	3447
2019 Q3	$3K	Sell	300 -1,300	-81%	-$17K	﹤0.01%	4893
2019 Q2	$25K	Buy	1,600 +1,500	+1,500%	+$21.7K	﹤0.01%	4088
2019 Q1	$1K	Sell	100 -3,900	-98%	-$44.1K	﹤0.01%	4700
2018 Q4	$38K	Buy	+4,000	New	+$51.9K	﹤0.01%	3696
2018 Q1	–	Sell	-2,000	Closed	-$31K	–	5557
2017 Q4	$31K	Buy	2,000 +900	+82%	+$12K	﹤0.01%	3974
2017 Q3	$12K	Hold	1,100	–	–	﹤0.01%	4248
2017 Q2	$10K	Buy	1,100 +500	+83%	+$4.17K	﹤0.01%	4227
2017 Q1	$5K	Buy	+600	New	+$5.47K	﹤0.01%	4306

Group One Trading's STML Position: Q2 2020 in Review

Group One Trading sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 26,780 shares — an estimated $130K sold.

Group One Trading first reported a position in STML in Q3 2015 and held it in 12 quarters. The position peaked at $130K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Group One Trading reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Group One Trading sold 26,780 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $130K.
Group One Trading first reported a position in Stemline Therapeutics, Inc. in Q3 2015 and held it in 12 quarters.
Group One Trading's Stemline Therapeutics, Inc. position peaked at $130K in Q1 2020.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.